Cargando…

Associations Between Target Lesion Restenosis and Drug-Eluting Balloon Use: An Observational Study

Percutaneous coronary interventions (PCIs) with drug-eluting balloons (DEBs) have emerged as an adjunctive treatment for in-stent restenosis (ISR) lesions. However, recurrent restenosis still occurs following DEB use. Our study aimed to identify the associations of target lesion restenosis following...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wei-Chieh, Wu, Chiung-Jen, Chen, Yung-Lung, Chung, Wen-Jung, Hsueh, Shu-Kai, Hang, Chi-Ling, Fang, Chih-Yuan, Fang, Hsiu-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998282/ https://www.ncbi.nlm.nih.gov/pubmed/26817908 http://dx.doi.org/10.1097/MD.0000000000002559

Ejemplares similares

One-year outcomes following drug-eluting balloon use for coronary ostial restenosis
por: Lee, Wei-Chieh, et al.
Publicado: (2015)

Aspiration Thrombectomy and Drug-Eluting Stent Implantation Decrease the Occurrence of Angina Pectoris One Year After Acute Myocardial Infarction
por: Lee, Wei-Chieh, et al.
Publicado: (2016)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Application of a snare technique in retrograde chronic total occlusion percutaneous coronary intervention – a step by step practical approach and an observational study
por: Fang, Hsiu-Yu, et al.
Publicado: (2016)

Comparison of rotational atherectomy and modified balloons prior to drug-eluting stent implantation for the treatment of heavily calcified coronary lesions
por: Hong, Xu-Lin, et al.
Publicado: (2021)

Total revascularization for an epsilon right coronary artery and severe left main disease combined with profound cardiogenic shock: A case report
por: Fang, Hsiu-Yu, et al.
Publicado: (2016)

How to treat the combination of coronary artery fistula and occluded coronary artery: A case report
por: Lee, Wei-Chieh, et al.
Publicado: (2018)

Validation of Scoring Systems That Predict Outcomes in Patients With Coronary Artery Disease Undergoing Coronary Artery Bypass Grafting Surgery
por: Chung, Wen-Jung, et al.
Publicado: (2015)

Drug-coated balloon versus drug-eluting stent in acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Geng, Baoyu, et al.
Publicado: (2021)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Abdelmegid, Mohamed Aboel-Kassem F., et al.
Publicado: (2017)

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study
por: Zhang, Juan, et al.
Publicado: (2022)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention
por: Zhang, Gai, et al.
Publicado: (2020)

Management of pulmonary embolism after recent intracranial hemorrhage: A case report
por: Lee, Wei-Chieh, et al.
Publicado: (2018)

Warning system improve the clinical outcomes in transfer patients with ST-segment elevation myocardial infarction
por: Fang, Hsiu-Yu, et al.
Publicado: (2021)

Neointimal coverage after second generation drug-eluting stent implantation has a relationship with pre-existing atherosclerotic lesion characteristics
por: Nomoto, Yohta, et al.
Publicado: (2019)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

A risk stratification scoring system for new-onset atrial fibrillation after ischemic stroke: A National cohort study
por: Chen, Yung-Lung, et al.
Publicado: (2020)

Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents
por: Su, Chieh-Shou, et al.
Publicado: (2019)

Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
por: Zhang, Haijun, et al.
Publicado: (2016)

Are Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?: A Systematic Review and Meta-Analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents: A systematic review and meta-analysis of 12 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

The effectiveness of Salvianolate injection for in-stent restenosis after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhang, Miao, et al.
Publicado: (2022)

Adverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents: A systematic review and meta-analysis of 10 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice
por: Krackhardt, Florian, et al.
Publicado: (2020)

Comparing efficacy of drug-coated balloon-only approach and stent approach in treating de novo coronary artery lesions: A meta-analysis of randomized controlled trials. A protocol for systematic review and meta-analysis
por: Yu, Deshuai, et al.
Publicado: (2020)

Three-year outcomes of bioresorbable vascular scaffolds versus second-generation drug-eluting stents: Meta-analysis of randomized trials
por: Ke, Junsong, et al.
Publicado: (2020)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Predictive value of miRNA-126 on in-stent restenosis in patients with coronary heart disease: A protocol for meta-analysis and bioinformatics analysis
por: Qiu, Xianke, et al.
Publicado: (2021)

Status and influencing factors of frailty in patients with restenosis after percutaneous transluminal angioplasty for peripheral arterial disease: A cross-sectional study
por: Zhu, Zhiping, et al.
Publicado: (2023)

Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer
por: Seo, Kyoung-Woo, et al.
Publicado: (2021)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
por: Cui, Kong-Yong, et al.
Publicado: (2018)

Balloon-expandable stents for native coarctation of the aorta in children and adolescents
por: Kasar, Taner, et al.
Publicado: (2022)

Cardiovascular outcomes associated with Ultrathin bioresorbable polymer sirolimus eluting stents versus thin, durable polymer everolimus eluting stents following percutaneous coronary intervention in patients with type 2 diabetes mellitus: A meta-analysis of published studies
por: Deng, Shibing, et al.
Publicado: (2020)

Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Liu, Shengxiang, et al.
Publicado: (2021)

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)

Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients
por: Chen, Mingli, et al.
Publicado: (2022)

Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study
por: Chen, I-Chih, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2hjoapl63psst90o2ghjeahl1t